Last Updated: November 13, 2026

Onesource Company Profile

« Back to Dashboard

What is the competitive landscape for ONESOURCE

ONESOURCE has forty-six approved drugs.

Summary for Onesource

US Patents:	0
Tradenames:	41
Ingredients:	37
NDAs:	46

Drugs and US Patents for Onesource

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Onesource Specialty	AMPICILLIN SODIUM	ampicillin sodium	INJECTABLE;INJECTION	201025-001	Apr 9, 2014		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Onesource Specialty	OXACILLIN SODIUM	oxacillin sodium	INJECTABLE;INJECTION	091486-001	Aug 25, 2014		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Onesource Specialty	OXACILLIN SODIUM	oxacillin sodium	INJECTABLE;INJECTION	091486-002	Aug 25, 2014	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
Onesource Specialty	NAFCILLIN SODIUM	nafcillin sodium	INJECTABLE;INJECTION	200002-001	Apr 7, 2014	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Onesource

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Onesource Specialty	VEPESID	etoposide	CAPSULE;ORAL	019557-001	Dec 30, 1986	3,524,844	⤷ Start Trial
Onesource Specialty	VEPESID	etoposide	CAPSULE;ORAL	019557-002	Dec 30, 1986	3,524,844	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Paragraph IV (Patent) Challenges for ONESOURCE drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	for Injection	100 mcg/vial and 500 mcg/vial	➤ Subscribe	2015-04-14
➤ Subscribe	for Injection	200 mcg/vial	➤ Subscribe	2015-05-01

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.